138499-26-0 Benzoic acid,2-[[[1-[[(4,6-dichloro-2-pyrimidinyl)amino]carbonyl]-3-methylbutyl]amino]carbonyl]-, (S)-
138504-31-1 4-FLUORO-2-IODOBENZOPHENONE
138501-34-5 1H-Naphth[2,3-d]imidazolium, 1,3-dibutyl-2-[5-(1,3-dibutyl-1,3,4,9-tetrahydro-4,9-dioxo-2H-naphth[2,3-d]imidazol-2-ylidene)-1,3-pentadien-1-yl]-4,9-dioxo-, perchlorate (1:1)
138502-91-7 Hydrazinecarboxylic acid, 2-[4-[(diphenoxyphosphinyl)amino]phenyl]-,(5-sulfo-2-thioxo-3(2H)-benzoxazolyl)methyl ester, monopotassium salt
133310-33-5 Prostavasin
133310-38-0 2,6-diamino-4-hydroxy-5-formamidopyrimidine
133310-71-1 Docosane, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-
13331-38-9 4,4-(Ethoxymethylene)bis(N,N-dimethylbenzenamine)
1333-15-9 2,2'-Methylenebis(6-chlorophenol)
133321-35-4 hexadecylphosphoserine
1333-21-7 tris(dinonylphenyl) phosphite
13332-20-2 cis-4-methylcyclohexyl acetate
13332-31-5 Butanoic acid, 2,3,3-trimethyl-, (2S)-
133323-49-6 Phosphine, 3,6,9,12,15-pentaoxaheptadecane-1,17-diylbis[diphenyl-
133323-68-9 2,3,5,6,7-Pentaselena-1,4-diphosphabicyclo[2.2.1]heptane
133325-76-5 Pyridinium, 1,1'-(1,4-butanediyl)bis[2-[(hydroxyimino)methyl]-,dibromide
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0